2009
DOI: 10.1128/aem.00294-09
|View full text |Cite
|
Sign up to set email alerts
|

Optimization of a Phage Amplification Assay To Permit Accurate Enumeration of Viable Mycobacterium avium subsp. paratuberculosis Cells

Abstract: A commercially available phage amplification assay, FASTPlaqueTB (Biotec Laboratories, Ipswich, United Kingdom), when used according to the manufacturer's instructions, does not permit accurate enumeration of Mycobacterium avium subsp. paratuberculosis. The aim of this study was to optimize the phage amplification assay conditions to permit accurate quantification of viable M. avium subsp. paratuberculosis cells. The burst time for M. avium subsp. paratuberculosis was initially determined to inform decisions a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
64
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
8
1

Relationship

5
4

Authors

Journals

citations
Cited by 47 publications
(66 citation statements)
references
References 37 publications
2
64
0
Order By: Relevance
“…paratuberculosis organisms in food or veterinary samples within 48 h using a commercially available phage amplification assay (FASTPlaqueTB assay; Biotec Laboratories Limited, Ipswich, United Kingdom), rather than waiting weeks for conventional culture results, is an exciting recent development (7,8,26). However, the mycobacteriophage used in the phage amplification assay has a broader mycobacterial host range than M. avium subsp.…”
mentioning
confidence: 99%
“…paratuberculosis organisms in food or veterinary samples within 48 h using a commercially available phage amplification assay (FASTPlaqueTB assay; Biotec Laboratories Limited, Ipswich, United Kingdom), rather than waiting weeks for conventional culture results, is an exciting recent development (7,8,26). However, the mycobacteriophage used in the phage amplification assay has a broader mycobacterial host range than M. avium subsp.…”
mentioning
confidence: 99%
“…Recently, we optimized a peptide-mediated magnetic separation-phage (PMS-phage) assay to rapidly detect viable M. avium subsp. paratuberculosis (4,5). PMS selectively captures and concentrates M. avium subsp.…”
mentioning
confidence: 99%
“…The phage assay was carried out as described by Foddai et al (2009). Briefly, 100 µL of D29 mycobacteriophage suspension (10 9 pfu/mL) was added to each bead sample, before incubation for 2 h at 37°C.…”
Section: Pms-phage Assaymentioning
confidence: 99%
“…However, detection methods for viable MAP in milk and dairy products have improved considerably over recent years with the advent of immunomagnetic separation (Grant et al, 1998;O'Brien et al, 2016) and subsequently peptide-mediated magnetic separation (PMS; Stratmann et al, 2002Stratmann et al, , 2006Foddai et al, 2010;O'Brien et al, 2016), which permit selective capture, separation, and concentration of whole MAP cells from a sample before culture or PCR, and novel mycobacteriophage-based methods of MAP detection (Stanley et al, 2007;Foddai et al, 2010;Swift et al, 2013;Botsaris et al, 2016), which require the MAP cells to be viable to obtain a positive result (plaques in a lawn of fast-growing Mycobacterium smegmatis). In particular, a method combining PMS and a phage amplification assay to detect MAP (PMS-phage assay), developed and optimized by Foddai et al (2009Foddai et al ( , 2011, and used in combination with an optimized milk sample preparation protocol (Foddai and Grant, 2015), is proving to be a very sensitive method of detecting viable MAP in cow milk. The optimized PMS-phage assay was recently reported to have a limit of detection 50% of ~1 MAP cell per 50 mL of milk, making it a more sensitive detection method than existing quantitative PCR for MAP and conventional culture methods (Foddai and Grant, 2017).…”
Section: Introductionmentioning
confidence: 99%